A novel point mutation within the juxtamembrane domain of theflt3gene in acute myeloid leukemia
✍ Scribed by Valentina Gianfelici; Daniela Diverio; Massimo Breccia; Sonia Buffolino; Valentina Derme; Attilio Di Lascio; Marilisa Marinelli; Simona Santangelo; Giovanna Meloni; Robin Foà
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 71 KB
- Volume
- 90
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract A myeloid leukemia cell line designated Kasumi‐6 was established from the bone marrow cells of an individual with acute myeloid leukemia, subtype M2. Both the original leukemic cells and the Kasumi‐6 cell line harbor a hemizygous point mutation in the gene encoding the CCAAT/enhancer bi
The ETV6 gene is a member of the ETS family of transcription factors and the main target of chromosomal rearrangements affecting chromosome band 12p13. To date, more than 15 fusion partners of ETV6 have been characterized at the molecular level. Most of these fusions encode chimeric proteins with on
Multiple epiphyseal dysplasia (MED) is a clinically variable and genetically heterogeneous chondrodysplasia characterized by mild to moderate short stature and early onset osteoarthritis. Some forms of MED result from mutations in the gene encoding the cartilage structural protein matrilin-3 (MATN3)